AMPYRA (Acorda Therapeutics, Inc.)


Welcome to the PulseAid listing for the AMPYRA drug offered from Acorda Therapeutics, Inc.. This Potassium Channel Blocker [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Acorda Therapeutics, Inc.
NON-PROPRIETARY NAME: Dalfampridine
SUBSTANCE NAME: DALFAMPRIDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Potassium Channel Blocker [EPC],Potassium Channel Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-03-01
END MARKETING DATE: 0000-00-00


AMPYRA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAMPYRA from Acorda Therapeutics, Inc.
LABELER NAME: Acorda Therapeutics, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2010-03-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10144-427_5a970cb6-fb01-1f85-e053-2a91aa0a4608
PRODUCT NDC: 10144-427
APPLICATION NUMBER: NDA022250

Other DALFAMPRIDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Acorda Therapeutics, Inc.AMPYRA